New iron supplement may be kinder to Kids' stomachs
NCT ID NCT05126901
First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tested a new iron supplement called ferric maltol (given as an oral suspension) against the standard ferrous sulfate liquid in children aged 2 to 17 with iron-deficiency anaemia, and also tested ferric maltol alone in infants aged 1 month to 2 years. The goal was to see if ferric maltol is safer and causes fewer stomach problems over 12 weeks. Researchers measured changes in haemoglobin and ferritin levels to check effectiveness.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
ferric maltol (an iron supplement)
What this could lead to
If it works, this could offer a better-tolerated iron supplement for children with iron-deficiency anaemia, potentially reducing stomach side effects.
What could go wrong
This is a small, completed phase 3 trial with only 65 participants, so results may not apply to all children. The new drug may still cause side effects or not work better than the standard treatment.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ANEMIA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Alder Hey Children's NHS Foundation Trust
Liverpool, United Kingdom
-
BRCR Global Puerto
San Juan, 00907, Puerto Rico
-
BRCR Global Texas
Edinburg, Texas, 78539, United States
-
Clinical Research Prime
Idaho Falls, Idaho, 83404, United States
-
Eminent Clinical Research and Associates
North Lauderdale, Florida, 33068, United States
-
Hasbro Children's Hospital
Providence, Rhode Island, 02903, United States
-
Homestead Research Institute
Homestead, Florida, 33030, United States
-
King's College Hospital
London, SE5 9RS, United Kingdom
-
Kissimmee Clinical Research Corp
Kissimmee, Florida, 34743, United States
-
Leicester Royal Infirmary
Leicester, LE1 5WW, United Kingdom
-
Levine Cancer Institute
Charlotte, North Carolina, 28204, United States
-
Medical Research of Westcheste
Miami, Florida, 33165, United States
-
Miami Clinical Research
Miami, Florida, 33155, United States
-
MultiCare Health System Institute for Research and Innovation
Tacoma, Washington, 98405, United States
-
Newham University Hospital
London, United Kingdom
-
Noah's Ark Children's Hospital for Wales
Cardiff, CF14 4XW, United Kingdom
-
Nottingham University Hospitals
Nottingham, NG7 2UH, United Kingdom
-
Penn State Hershey Children's Hospital
Hershey, Pennsylvania, 17033, United States
-
Royal Hospital for Sick Children - Edinburgh
Edinburgh, EH16 4TJ, United Kingdom
-
Royal Manchester Children's Hospital
Manchester, M13 9WL, United Kingdom
-
Sierra Clinical Research
Las Vegas, Nevada, 89106, United States
-
The Center for Clinical Trials
Saraland, Alabama, 36571, United States
-
Zion Research
Katy, Texas, 77494, United States